Back
Aquestive Therapeutics Vs. Supernus Pharmaceuticals Industry Stock Comparison
Buy
61
AQST
Aquestive Therapeutics
Last Price:
4.94
Seasonality Move:
11.7%
Sell
24
SUPN
Supernus Pharmaceuticals
Last Price:
31.82
Seasonality Move:
-9.35%
Buy
61
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $4.79. The Score for AQST is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- AQST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
24
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $31.72. The Score for SUPN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $4.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing selling pressure, which indicates risk of future bearish movement.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $31.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SUPN is experiencing slight selling pressure.
AQST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 59.29 | Buy |
Chaikin Money Flow: | -1013149 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.16 - 4.72) | Buy |
Bollinger Bands (100): | (2.7 - 4.12) | Buy |
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 42.19 | Sell |
Chaikin Money Flow: | -52853 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.43 - 35.15) | Sell |
Bollinger Bands (100): | (26.98 - 32.66) | Buy |
AQST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.69 | Buy |
20-day SMA: | 4.53 | Buy |
50-day SMA: | 3.84 | Buy |
200-day SMA: | 3.31 | Buy |
8-day EMA: | 4.71 | Buy |
20-day EMA: | 4.47 | Buy |
50-day EMA: | 4.01 | Buy |
200-day EMA: | 3.27 | Buy |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.19 | Sell |
20-day SMA: | 33.74 | Sell |
50-day SMA: | 31.73 | Sell |
200-day SMA: | 29.72 | Buy |
8-day EMA: | 32.16 | Sell |
20-day EMA: | 32.81 | Sell |
50-day EMA: | 31.89 | Sell |
200-day EMA: | 30.31 | Buy |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Aquestive Therapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Supernus Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |